Investigation of NDM, VIM, KPC and OXA-48 genes, blue-carba and CIM in carbapenem resistant Enterobacterales isolates.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 05 2021
Historique:
received: 25 06 2020
accepted: 15 10 2020
entrez: 9 6 2021
pubmed: 10 6 2021
medline: 4 1 2022
Statut: epublish

Résumé

Carbapenem resistance is an emerging problem in Enterobactarales. We aimed to investigate the presence of carbapenemase genes blaNDM, blaKPC, blaVIM and blaOXA-48 and evaluate the phenotypic blue-carba method and carbapenem inactivation method (CIM) in Enterobacterales isolates. Total of 153 Enterobacterales isolates were tested in the study. Presence of blaNDM, blaKPC, blaVIM and blaOXA-48 genes was investigated by polymerase chain reaction (PCR) method. Carbapenemase production of the isolates was also tested by blue-carba method and CIM. The presence of blaOXA-48 gene was detected in 110 (71.4%) and blaNDM gene was detected in 2 (1.3%) of the Enterobacterales isolates by PCR method. None of the isolates were positive for blaKPC and blaVIM genes. The 121 (78.54%) of the isolates were found to be positive by blue-carba method and CIM. And 105 (68.18%) of the isolates were determined as positive by both PCR, blue-carba and CIM. In our study, 112 (72.7%) of the Enterobacterales isolates were found to be positive for carbapenemase genes (blaoxa-48 and blaNDM), and 121 (78.57%) of different isolates were found to be positive for blue-carba and CIM. However, 105 (68.18%) of the carbapenem resistance isolates found to be positive for all three methods.

Identifiants

pubmed: 34106894
doi: 10.3855/jidc.13345
doi:

Substances chimiques

Anti-Bacterial Agents 0
DNA, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

696-703

Informations de copyright

Copyright (c) 2021 Yeliz Tanriverdi Cayci, Ilknur Biyik, Ferhan Korkmaz, Asuman Birinci.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Yeliz Tanriverdi Cayci (Y)

Department of Medical Microbiology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey. yeliztanriverdi@gmail.com.

Ilknur Biyik (I)

Department of Medical Microbiology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.

Ferhan Korkmaz (F)

Rize State Hospital, Microbiology Laboratory, Rize, Turkey.

Asuman Birinci (A)

Department of Medical Microbiology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH